| MeSH term | MeSH ID | Detail |
|---|---|---|
| Edema | D004487 | 152 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Angina Pectoris | D000787 | 27 associated lipids |
Total
3
Tribehenin
Tribehenin is a lipid of Glycerolipids (GL) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Tribehenin
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tribehenin
NCBI Entrez Crosslinks
All references with Tribehenin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Makwana V et al. | Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. | 2015 | Int J Pharm | pmid:26367780 |
| Kakkar S et al. | Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. | 2015 | Int J Pharm | pmid:26325312 |
| Jeong KH et al. | Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate. | 2015 | Int J Pharm | pmid:26315121 |
| Zhang W et al. | Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. | 2013 | Int J Pharm | pmid:23876384 |
| Bose S et al. | Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. | 2013 | Int J Pharm | pmid:23262430 |
| Wolska E and Sznitowska M | Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM). | 2013 | Int J Pharm | pmid:23164704 |
| MartÃnez-Acevedo L et al. | Evaluation of the lubricating effect of magnesium stearate and glyceryl behenate solid lipid nanoparticles in a direct compression process. | 2018 | Int J Pharm | pmid:29729408 |
| Schöler N et al. | Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. | 2000 | Int J Pharm | pmid:10699726 |
| Blasi P et al. | Lipid nanoparticles for brain targeting I. Formulation optimization. | 2011 | Int J Pharm | pmid:21827844 |
| Gaspar DP et al. | Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies. | 2016 | Int J Pharm | pmid:26656946 |